SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries B Convertible Preferred Stock Purchase Agreement • October 20th, 2010 • MultiCell Technologies, Inc. • Surgical & medical instruments & apparatus • Nevada
This Series B Convertible Preferred Stock Purchase Agreement (this "Agreement") is made as of October 14, 2010, by and among Xenogenics Corporation, a Nevada corporation (the "Company"), and the Multicell Technologies, Inc., a Delaware corporation (the "Purchaser").
FORECLOSURE SALE AGREEMENTForeclosure Sale Agreement • October 20th, 2010 • MultiCell Technologies, Inc. • Surgical & medical instruments & apparatus • California
This FORECLOSURE SALE AGREEMENT (the “Agreement”) is entered into as of September ___, 2010 by and among Venture Lending & Leasing IV, Inc. (“VLL4”), Venture Lending & Leasing V, Inc. (“VLL5”), Silicon Valley Bank (“SVB”) and Xenogenics Corporation, a Nevada corporation (“Purchaser”). VLL4, VLL5 and SVB are sometimes referred to hereinafter collectively, as “Sellers” and individually as a “Seller” and VLL5, in its capacity as collateral agent for the Sellers under the Loan Agreement (as defined below) is sometimes referred to herein as “Agent.”
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 20th, 2010 • MultiCell Technologies, Inc. • Surgical & medical instruments & apparatus • New Jersey
THIS LICENSE AGREEMENT (the “Agreement”) is made and is effective as of September 30, 2010, (the “Effective Date”) by and between RUTGERS, THE STATE UNIVERSITY, having its statewide Office of Technology Commercialization at 3 Rutgers Plaza, New Brunswick, New Jersey 08901, (hereinafter referred to as “Rutgers”), and Xenogenics Corporation, a Nevada Corporation, a having a principal place of business at 68 Cumberland Street, Suite 301, Woonsocket, RI 02895 (hereinafter referred to as “Licensee”).
